Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12

Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12

Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12

Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12

Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12

Parse error: syntax error, unexpected ')' in /home/sites/spiriva.com/web/public/uk/sites/all/modules/rules/modules/php.eval.inc(146) : eval()'d code on line 12
Asthma Statistics | People Affected | Spiriva Respimat
Skip to main content

The evidence on the burden of asthma | Spiriva Respimat

Evidence on the burden of asthma

A very common chronic disease, asthma accounts for around 1% of disability-adjusted life years lost.5 By 2025, the number of people affected may grow by 100m6

Across Europe some 30 million children and adults under the age of 45 live with asthma1; globally the figure is around 10 times that number with the global prevalence ranging from 1% to 18% of the population in different countries.2 As a common chronic disease with no current cure, asthma places a considerable burden on individuals, society in general and healthcare systems.1,3

Keeping patients at the centre

Direct costs within the EU have been estimated at around €20 billion, indirect costs at €14 billion and the monetised value of disability-adjusted life years (DALYs) at €38 billion –a total of €72 billion.4 15,000 people are estimated to die each year from asthma in Europe and 4 million hospitalised between now and 2020, prompting the European Union to look to the European Asthma Research and Innovation Partnership (EARIP) to identify the practices and processes that will keep patients at the centre of asthma management and treatment.4,5

There’s a big problem...

Persistent symptomatic asthma impacts lives. See our latest infographic

References

  1. European Respiratory Society. European Lung White Book, Chapter 12 Adult Asthma. Available at: http://www.erswhitebook.org/chapters/adult-asthma/. Accessed 28/07/16
  2. Demoly P, et al. Eur Respir Rev 2010; 19: 116, 150–157
  3. Bahadori K, et al. BMC Pulm Med 2009; 9: 24
  4. Selroos O, et al. Eur Respir Rev 2015; 24: 474–483
  5. Bousquets J et al. Bulletin of the WHO 2005; 83:548-554
  6. Masoli M et al. Allergy 2004; 59:469-478